HuGE Literature Finder
|
||
Records 1-100
|
Thyroid Carcinoma Coexisting with Hashimoto's Thyreoiditis: Clinicopathological and Molecular Characteristics Clue up Pathogenesis.
Pathology oncology research : POR 2019 Jan . Molnár Csaba, Molnár Sarolta, Bedekovics Judit, Mokánszki Attila, Gyory Ferenc, Nagy Endre, Méhes Gáb |
|
Diagnostic value and lymph node metastasis prediction of a custom?made panel (thyroline) in thyroid cancer.
Oncology reports 2018 Jun . Ke Zunfu, Liu Yihao, Zhang Yunjian, Li Jie, Kuang Ming, Peng Sui, Liang Jinyu, Yu Shuang, Su Lei, Chen Lili, Sun Cong, Li Bin, Cao Jessica, Lv Weiming, Xiao Haipe |
|
Efficacy and safety of single-agent pan-human epidermal growth factor receptor (HER) inhibitor dacomitinib in locally advanced unresectable or metastatic skin squamous cell cancer.
European journal of cancer (Oxford, England : 1990) 2018 May 97 7-15. Cavalieri S, Perrone F, Miceli R, Ascierto P A, Locati L D, Bergamini C, Granata R, Alfieri S, Resteghini C, Galbiati D, Busico A, Paielli N, Patuzzo R, Maurichi A, Gallino G, Ruggeri R, Mariani L, Palla M, Licitra L, Bossi |
|
Multifactorial Analysis of Prognostic Factors and Survival Rates Among 706 Mucosal Melanoma Patients.
Annals of surgical oncology 2018 May . Cui ChuanLiang, Lian Bin, Zhou Li, Song Xin, Zhang XiaoShi, Wu Di, Chi ZhiHong, Si Lu, Sheng XiNan, Kong Yan, Tang BiXia, Mao LiLi, Wang Xuan, Li SiMing, Dai Jie, Yan XieQiao, Bai Xue, Balch Charles M, Guo J |
|
KRAS and 2 rare PI3KCA mutations coexisting in a metastatic colorectal cancer patient with aggressive and resistant disease.
Human pathology 2018 Apr 74 178-182. Tessitore Alessandra, Bruera Gemma, Mastroiaco Valentina, Cannita Katia, Cortellini Alessio, Cocciolone Valentina, Dal Mas Antonella, Calvisi Giuseppe, Zazzeroni Francesca, Ficorella Corrado, Ricevuto Enrico, Alesse Edoar |
|
Podoplanin-positive cancer-associated fibroblast recruitment within cancer stroma is associated with a higher number of single nucleotide variants in cancer cells in lung adenocarcinoma.
Journal of cancer research and clinical oncology 2018 Mar . Nakasone Shoko, Mimaki Sachiyo, Ichikawa Tomohiro, Aokage Keiju, Miyoshi Tomohiro, Sugano Masato, Kojima Motohiro, Fujii Satoshi, Kuwata Takeshi, Ochiai Atsushi, Tsuboi Masahiro, Goto Koichi, Tsuchihara Katsuya, Ishii Genichi |
|
<i>BRAF</i> and <i>RAS</i> mutational status in non-invasive follicular thyroid neoplasm with papillary-like nuclear features and invasive subtype of encapsulated follicular variant of papillary thyroid carcinoma in Korea.
Thyroid : official journal of the American Thyroid Association 2018 Feb . Kim Mijin, Jeon MinJi, Oh Hye-Seon, Park Suyeon, Kim Tae Yong, Shong YoungKee, Kim Won Bae, Kim Kyunggon, Kim Won Gu, Song Dong E |
|
Correlations of IGF-1R and COX-2 Expressions with Ras and BRAF Genetic Mutations, Clinicopathological Features and Prognosis of Colorectal Cancer Patients.
Pathology oncology research : POR 2017 Feb . Jin Mei, Long Zi-Wen, Yang Jing, Lin Xia |
|
High prevalence of concomitant oncogene mutations in prospectively identified patients with ROS1-positive metastatic lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2016 Aug . Wiesweg Marcel, Eberhardt Wilfried E E, Reis Henning, Ting Saskia, Savvidou Nikoleta, Skiba Charlotte, Herold Thomas, Christoph Daniel C, Meiler Johannes, Worm Karl, Kasper Stefan, Theegarten Dirk, Hense Jörg, Hager Thomas, Darwiche Kaid, Oezkan Filiz, Aigner Clemens, Welter Stefan, Kühl Hilmar, Stuschke Martin, Schmid Kurt W, Schuler Mart |
|
Vemurafenib in patients with BRAF(V600E)-positive metastatic or unresectable papillary thyroid cancer refractory to radioactive iodine: a non-randomised, multicentre, open-label, phase 2 trial.
The Lancet. Oncology 2016 Jul . Brose Marcia S, Cabanillas Maria E, Cohen Ezra E W, Wirth Lori J, Riehl Todd, Yue Huibin, Sherman Steven I, Sherman Eric |
|
[Relationship and clinical significance between mutated BRAF with prophylactic central-neck nodal dissection in papillary thyroid carcinoma].
Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences 2016 Jun 48 (3): 502-6. Zhang Y J, Liu B G, Zhao Z Y, Sheng J D, Feng D |
|
Metadherin Expression is Associated with Extrathyroidal Extension in Papillary Thyroid Cancer Patients.
Annals of surgical oncology 2016 May . Moore Robert F, Sholl Andrew B, Kidd Laura, Al-Qurayshi Zaid, Tsumagari Koji, Emejulu Obinwanne M, Kholmatov Roostam, Friedlander Paul, Abd Elmageed Zakaria Y, Kandil Em |
|
Morphological and molecular approach to synchronous non-small cell lung carcinomas: impact on staging.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2016 Apr . Schneider Frank, Derrick Veronica, Davison Jon M, Strollo Diane, Incharoen Pimpin, Dacic San |
|
Detection of PIK3CA mutations, including a novel mutation of V344G in exon 4, in metastatic lung adenocarcinomas: A retrospective study of 115 FNA cases.
Cancer cytopathology 2016 Mar . Allison Derek B, Lilo Mohammed T, Geddes Susan, Pallavajjalla Aparna, Askin Frederic, Gabrielson Edward, Zheng Gang, Li Qing K |
|
Medullary carcinoma in the colorectum: a systematic review and meta-analysis.
Human pathology 2016 Mar . Pyo Jung-Soo, Sohn Jin Hee, Kang Guhy |
|
Whole exome sequencing identifies lncRNA GAS8-AS1 and LPAR4 as novel papillary thyroid carcinoma driver alternations.
Human molecular genetics 2016 Mar . Pan Wenting, Zhou Liqing, Ge Minghua, Zhang Bin, Yang Xinyu, Xiong Xiangyu, Fu Guobin, Zhang Jian, Nie Xilin, Li Hongmin, Tang Xiaohu, Wei Jinyu, Shao Mingming, Zheng Jian, Yuan Qipeng, Tan Wen, Wu Chen, Yang Ming, Lin Dongx |
|
Meta-Analyses of Association Between BRAFV600E Mutation and Clinicopathological Features of Papillary Thyroid Carcinoma.
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2016 Feb 38 (2): 763-776. Zhang Qing, Liu Shao-Zheng, Zhang Qing, Guan Yan-Xing, Chen Qing-Jie, Zhu Qin-Y |
|
Sub-clonality for BRAF mutation in papillary thyroid carcinoma is associated with earlier disease stage.
The Journal of clinical endocrinology and metabolism 2016 Feb jc20154031. Finkel Alona, Liba Lior, Simon Einav, Bick Tova, Prinz Elad, Sabo Edmond, Ben-Izhak Ofer, Hershkovitz D |
|
Stomatin-like protein 2 overexpression in papillary thyroid carcinoma is significantly associated with high-risk clinicopathological parameters and BRAFV600E mutation.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2016 Jan . Bartolome Aleksandar, Boskovic Srdjan, Paunovic Ivan, Bozic Vesna, Cvejic Dubrav |
|
Associations between BRAF(V600E) and prognostic factors and poor outcomes in papillary thyroid carcinoma: a meta-analysis.
World journal of surgical oncology 2016 14 (1): 241. Liu Chunping, Chen Tianwen, Liu Zemi |
|
Distribution of KRAS and BRAF Mutations in Metastatic Colorectal Cancers in Turkish Patients.
Asian Pacific journal of cancer prevention : APJCP 2016 17 (3): 1175-9. Gorukmez Orhan, Yakut Tahsin, Gorukmez Ozlem, Sag Sebnem Ozemri, Karkucak Mutlu, Kanat Ozk |
|
Significance of the BRAF mRNA Expression Level in Papillary Thyroid Carcinoma: An Analysis of The Cancer Genome Atlas Data.
PloS one 2016 11 (7): e0159235. Chai Young Jun, Yi Jin Wook, Jee Hyeon-Gun, Kim Young A, Kim Ju Han, Xing Mingzhao, Lee Kyu E |
|
Association Between GWAS-derived rs966423 Genetic Variant and Overall Mortality in Patients with Differentiated Thyroid Cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2015 Oct . Swierniak Micha?, Wojcicka Anna, Czetwertynska Ma?gorzata, D?ugosinska Joanna, Stachlewska Elzbieta, Gierlikowski Wojciech, Kot Adam, Gornicka Barbara, Koperski Lukasz, Bogdanska Magdalenia, Wiechno Wieslaw, Jazdzewski Krysti |
|
Strong immunoexpression of midkine is associated with multiple lymph node metastases in BRAFV600E papillary thyroid carcinoma.
Human pathology 2015 Oct 46 (10): 1557-65. Choi Yong Won, Kim Young Hwa, Lee Jeonghun, Soh Euy Young, Park Tae Jun, Kim Jang-H |
|
Expression of the hyaluronan-mediated motility receptor RHAMM in tumor budding cells identifies aggressive colorectal cancers.
Human pathology 2015 Jul . Koelzer Viktor Hendrik, Huber Bettina, Mele Valentina, Iezzi Giandomenica, Trippel Mafalda, Karamitopoulou Eva, Zlobec Inti, Lugli Alessand |
|
Identification of KRAS and PIK3CA but not BRAF mutations in patients with gastric cancer.
Molecular medicine reports 2015 Jul 12 (1): 1219-24. Lu Weipeng, Wei Hong, Li Mei, Wang Hai, Liu Lina, Zhang Qiuping, Liu Lisha, Lu Sh |
|
Real-Time PCR Cycle Threshold Values for the BRAFV600E Mutation in Papillary Thyroid Microcarcinoma May Be Associated With Central Lymph Node Metastasis: A Retrospective Study.
Medicine 2015 Jul 94 (28): e1149. Park Vivian Y, Kim Eun-Kyung, Lee Hye Sun, Moon Hee Jung, Yoon Jung Hyun, Kwak Jin You |
|
Potential relationship between Hashimoto's thyroiditis and BRAF(V600E) mutation status in papillary thyroid cancer.
Head & neck 2015 Jun . Zeng Rui-Chao, Jin Lang-Ping, Chen En-Dong, Dong Si-Yang, Cai Ye-Feng, Huang Guan-Li, Li Quan, Jin Chun, Zhang Xiao-Hua, Wang Ou-Ch |
|
Role of BRAF V600E mutation as an indicator of the extent of thyroidectomy and lymph node dissection in conventional papillary thyroid carcinoma.
Surgery 2015 Jun . Kim Seo Ki, Woo Jung-Woo, Lee Jun Ho, Park Inhye, Choe Jun-Ho, Kim Jung-Han, Kim Jee S |
|
Detection of plasma BRAF(V600E) mutation is associated with lung metastasis in papillary thyroid carcinomas.
Yonsei medical journal 2015 May 56 (3): 634-40. Kim Bo Hyun, Kim In Joo, Lee Byung Joo, Lee Jin Choon, Kim In Suk, Kim Seong-Jang, Kim Won Jin, Jeon Yun Kyung, Kim Sang Soo, Kim Yong |
|
MicroRNA and mRNA expression profiling in metastatic melanoma reveal associations with BRAF mutation and patient prognosis.
Pigment cell & melanoma research 2015 May 28 (3): 254-66. Tembe Varsha, Schramm Sarah-Jane, Stark Mitchell S, Patrick Ellis, Jayaswal Vivek, Tang Yue Hang, Barbour Andrew, Hayward Nicholas K, Thompson John F, Scolyer Richard A, Yang Yee Hwa, Mann Graham |
|
BRAFV600E mutation in papillary thyroid microcarcinoma: a meta-analysis.
Endocrine-related cancer 2015 Apr 22 (2): 159-68. Li Fei, Chen Guangqi, Sheng Chunjun, Gusdon Aaron M, Huang Yueye, Lv Zhongwei, Xu Huixiong, Xing Mingzhao, Qu Sh |
|
MicroRNA-224 is associated with colorectal cancer progression and response to 5-fluorouracil-based chemotherapy by KRAS-dependent and -independent mechanisms.
British journal of cancer 2015 Apr 112 (9): 1480-90. Amankwatia E B, Chakravarty P, Carey F A, Weidlich S, Steele R J C, Munro A J, Wolf C R, Smith |
|
Genomic analysis of metastatic cutaneous squamous cell carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2015 Mar 21 (6): 1447-56. Li Yvonne Y, Hanna Glenn J, Laga Alvaro C, Haddad Robert I, Lorch Jochen H, Hammerman Peter |
|
[Association between BRAF V600E mutation and central lymph node metastasis in patients with papillary thyroid carcinoma].
Zhonghua zhong liu za zhi [Chinese journal of oncology] 2015 Feb 37 (2): 123-7. Shi Chenlei, Qin Huadong, Ding Chao, Sun Yu, Lyu Yichen, Shi Tiefe |
|
Clinicopathologic correlations of the BRAFV600E mutation, BRAF V600E immunohistochemistry, and BRAF RNA in situ hybridization in papillary thyroid carcinoma.
Pathology, research and practice 2015 Feb 211 (2): 162-70. Jung Yoon Yang, Yoo Jae Hyung, Park Eon Sub, Kim Mi Kyung, Lee Tae Jin, Cho Bo Youn, Chung Yun Jae, Kang Kyung Ho, Ahn Hwa Young, Kim Hee Su |
|
Lymph node metastases of melanoma: challenges for BRAF mutation detection.
Human pathology 2015 Jan 46 (1): 113-9. Chen Guoli, Dudley Jonathan, Tseng Li-Hui, Smith Kirstin, Gurda Grzegorz T, Gocke Christopher D, Eshleman James R, Lin Ming-Ts |
|
Association between BRAF V600E mutation and regional lymph node metastasis in papillary thyroid carcinoma.
International journal of clinical and experimental pathology 2015 8 (1): 793-9. Lu Junliang, Gao Jie, Zhang Jing, Sun Jian, Wu Huanwen, Shi Xiaohua, Teng Lianghong, Liang Zhiyo |
|
Colorectal carcinomas with KRAS codon 12 mutation are associated with more advanced tumor stages.
BMC cancer 2015 15 (1): 340. Li Wenbin, Qiu Tian, Zhi Wenxue, Shi Susheng, Zou Shuangmei, Ling Yun, Shan Ling, Ying Jianming, Lu Ni |
|
Targeted DNA Sequencing Detects Mutations Related to Susceptibility among Familial Non-medullary Thyroid Cancer.
Scientific reports 2015 5 16129. Yu Yang, Dong Li, Li Dapeng, Chuai Shaokun, Wu Zhigang, Zheng Xiangqian, Cheng Yanan, Han Lei, Yu Jinpu, Gao Mi |
|
[Correlation between BRAF V600E mutation and clinicopathologic features of papillary thyroid carcinoma].
Zhonghua bing li xue za zhi Chinese journal of pathology 2014 Dec 43 (12): 794-8. Lu Haizhen, Qiu Tian, Ying Jianming, Guo Changyuan, Lyn Ni |
|
Molecular characterization and patient outcome of melanoma nodal metastases and an unknown primary site.
Annals of surgical oncology 2014 Dec 21 (13): 4317-23. Gos Aleksandra, Jurkowska Monika, van Akkooi Alexander, Robert Caroline, Kosela-Paterczyk Hanna, Koljenovi? Senada, Kamsukom Nyam, Michej Wanda, Jeziorski Arkadiusz, Pluta Piotr, Verhoef Cornelis, Siedlecki Janusz A, Eggermont Alexander M M, Rutkowski Pio |
|
Genomic profiling of intrahepatic cholangiocarcinoma: refining prognosis and identifying therapeutic targets.
Annals of surgical oncology 2014 Nov 21 (12): 3827-34. Zhu Andrew X, Borger Darrell R, Kim Yuhree, Cosgrove David, Ejaz Aslam, Alexandrescu Sorin, Groeschl Ryan Thomas, Deshpande Vikram, Lindberg James M, Ferrone Cristina, Sempoux Christine, Yau Thomas, Poon Ronnie, Popescu Irinel, Bauer Todd W, Gamblin T Clark, Gigot Jean Francois, Anders Robert A, Pawlik Timothy |
|
[Association of BRAF(V) 600E mutation with clinical pathological features in papillary thyroid carcinoma: meta-analysis].
Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery 2014 Sep 49 (9): 759-64. Yan Kangkang, Lin Xuejun, Li Shuang, Bao Honghong, Zhao Longyu, Liu X |
|
Progression-free survival remains poor over sequential lines of systemic therapy in patients with BRAF-mutated colorectal cancer.
Clinical colorectal cancer 2014 Sep 13 (3): 164-71. Morris Van, Overman Michael J, Jiang Zhi-Qin, Garrett Christopher, Agarwal Shweta, Eng Cathy, Kee Bryan, Fogelman David, Dasari Arvind, Wolff Robert, Maru Dipen, Kopetz Sco |
|
The BRAF(V600E) mutation influences the short- and medium-term outcomes of classic papillary thyroid cancer, but is not an independent predictor of unfavorable outcome.
Thyroid : official journal of the American Thyroid Association 2014 Aug 24 (8): 1267-74. Russo Marco, Malandrino Pasqualino, Nicolosi Maria Luisa, Manusia Mario, Marturano Ilenia, Trovato Maria Antonietta, Pellegriti Gabriella, Frasca Francesco, Vigneri Riccar |
|
Is BRAF a prognostic factor in stage III skin melanoma? A retrospective study of 72 patients after positive sentinel lymph node dissection.
The British journal of dermatology 2014 Jul 171 (1): 108-14. Picard M, Pham Dang N, D'Incan M, Mansard S, Dechelotte P, Pereira B, Mondie J M, Barthelemy |
|
Correlation among the BRAF gene mutation status, clinicopathological features of primary tumour, and lymph node metastasizing of papillary thyroid carcinoma.
Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 2014 May 122 (5): 268-72. Lukas J, Drabek J, Dudesek B, Vazan P, Stranska J, Jancik S, Mackova M, Syrucek M, Lukas D, Duskova J, Dundr P, Hintnausova B, Jiskra |
|
Clinical significance of the BRAF V600E mutation in multifocal papillary thyroid carcinoma in Korea.
Surgery 2014 Apr 155 (4): 689-95. Ahn Hwa Young, Chung Yun Jae, Kim Byung Seup, Kang Kyung Ho, Seok Ju Won, Kim Hee Sung, Park Sung Jun, Cho Bo Yo |
|
BRAF(V600E) mutation analysis in papillary thyroid carcinoma: is it useful for all patients?
World journal of surgery 2014 Mar 38 (3): 679-87. Ito Yasuhiro, Yoshida Hiroshi, Kihara Minoru, Kobayashi Kaoru, Miya Akihiro, Miyauchi Aki |
|
Frequency, characterization, and prognostic analysis of PIK3CA gene mutations in Chinese esophageal squamous cell carcinoma.
Human pathology 2014 Feb 45 (2): 352-8. Hou Jun, Jiang Dongxian, Zhang Jingchuan, Gavine Paul R, Xu Songtao, Liu Yalan, Xu Chen, Huang Jie, Tan Yunshan, Wang Hao, Lu Yachao, Zheng Li, Hou Yingyong, Tan Lij |
|
Associations of the BRAF(V600E) mutation with sonographic features and clinicopathologic characteristics in a large population with conventional papillary thyroid carcinoma.
PloS one 2014 9 (10): e110868. Park Ah Young, Son Eun Ju, Kim Jeong-Ah, Youk Ji Hyun, Park Yun Joo, Park Cheong Soo, Chang Hang Se |
|
Comparison of neuroendocrine differentiation and KRAS/NRAS/BRAF/PIK3CA/TP53 mutation status in primary and metastatic colorectal cancer.
International journal of clinical and experimental pathology 2014 7 (9): 5927-39. Kleist Britta, Kempa Marcel, Novy Michael, Oberkanins Christian, Xu Li, Li Guojun, Loland Christiane, Poetsch Micae |
|
Quantification of BRAF V600E alleles predicts papillary thyroid cancer progression.
Endocrine-related cancer 2014 21 (6): 891-902. Kim Min-Hee, Bae Ja Seong, Lim Dong-Jun, Lee Hyoungnam, Jeon So Ra, Park Gyeong Sin, Jung Chan Kw |
|
Molecular and clinical characteristics of MSH6 germline variants detected in colorectal cancer patients.
Oncology reports 2013 Dec 30 (6): 2909-16. Terui Hiroko, Tachikawa Tetsuhiko, Kakuta Miho, Nishimura Yoji, Yatsuoka Toshimasa, Yamaguchi Kensei, Yura Kei, Akagi Kiwa |
|
Tall cell variant of papillary thyroid microcarcinoma: clinicopathologic features with BRAF(V600E) mutational analysis.
Thyroid : official journal of the American Thyroid Association 2013 Dec 23 (12): 1525-31. Bernstein Jane, Virk Renu K, Hui Pei, Prasad Avinash, Westra William H, Tallini Giovanni, Adeniran Adebowale J, Udelsman Robert, Sasaki Clarence T, Roman Sanziana A, Sosa Julie A, Prasad Manju |
|
The prognostic significance of the BRAF V600E mutation in papillary thyroid carcinoma detected by mutation-specific immunohistochemistry.
Pathology 2013 Dec 45 (7): 637-44. McKelvie Penelope A, Chan Fiona, Yu Yong, Waring Paul, Gresshoff Irma, Farrell Stephen, Williams Richard |
|
[Invasiveness of papillary thyroid microcarcinoma with BRAF mutation].
Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae 2013 Aug 35 (4): 398-403. Yang Xue, Liang Zhi-yong, Meng Chao, Liang Jun, Yu Zhuang, Lin Yan-so |
|
Methylation levels of LINE-1 in primary lesion and matched metastatic lesions of colorectal cancer.
British journal of cancer 2013 Jul 109 (2): 408-15. Murata A, Baba Y, Watanabe M, Shigaki H, Miyake K, Ishimoto T, Iwatsuki M, Iwagami S, Sakamoto Y, Miyamoto Y, Yoshida N, Nosho K, Baba |
|
Allele percentage of the BRAF V600E mutation in papillary thyroid carcinomas and corresponding lymph node metastases: no evidence for a role in tumor progression.
The Journal of clinical endocrinology and metabolism 2013 May 98 (5): E934-42. Gandolfi Greta, Sancisi Valentina, Torricelli Federica, Ragazzi Moira, Frasoldati Andrea, Piana Simonetta, Ciarrocchi Aless |
|
Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer.
JAMA 2013 Apr 309 (14): 1493-501. Xing Mingzhao, Alzahrani Ali S, Carson Kathryn A, Viola David, Elisei Rossella, Bendlova Bela, Yip Linwah, Mian Caterina, Vianello Federica, Tuttle R Michael, Robenshtok Eyal, Fagin James A, Puxeddu Efisio, Fugazzola Laura, Czarniecka Agnieszka, Jarzab Barbara, O'Neill Christine J, Sywak Mark S, Lam Alfred K, Riesco-Eizaguirre Garcilaso, Santisteban Pilar, Nakayama Hirotaka, Tufano Ralph P, Pai Sara I, Zeiger Martha A, Westra William H, Clark Douglas P, Clifton-Bligh Roderick, Sidransky David, Ladenson Paul W, Sykorova Vlas |
|
Correlation of immunohistochemical markers and BRAF mutation status with histological variants of papillary thyroid carcinoma in the Korean population.
Journal of Korean medical science 2013 Apr 28 (4): 534-41. Min Hye Sook, Lee Chul, Jung Kyeong Che |
|
The rs6983267 SNP is associated with MYC transcription efficiency, which promotes progression and worsens prognosis of colorectal cancer.
Annals of surgical oncology 2013 Apr 20 (4): 1395-402. Takatsuno Yasushi, Mimori Koshi, Yamamoto Ken, Sato Tetsuya, Niida Atsushi, Inoue Hiroshi, Imoto Seiya, Kawano Shuhei, Yamaguchi Rui, Toh Hiroyuki, Iinuma Hisae, Ishimaru Shinya, Ishii Hideshi, Suzuki Sadao, Tokudome Shinkan, Watanabe Masahiko, Tanaka Jun-Ichi, Kudo Shin-Ei, Mochizuki Hidetaka, Kusunoki Masato, Yamada Kazutaka, Shimada Yasuhiro, Moriya Yoshihiro, Miyano Satoru, Sugihara Kenichi, Mori Masa |
|
Clinicopathologic implications of the BRAFV600E mutation in papillary thyroid cancer; a subgroup analysis of 3130 cases in a single center.
Thyroid : official journal of the American Thyroid Association 2013 Mar . Lim JY, Hong SW, Lee YS, Kim BW, Park CS, Chang HS, Cho JY |
|
Clinical implication of the BRAFV600E mutation in papillary thyroid carcinoma.
World journal of surgical oncology 2013 11 99. Kim Yong-Seok, Kim Jeong-Soo, Bae Ja-Seong, Park Woo-Ch |
|
The relationship between the BRAF(V600E) mutation in papillary thyroid microcarcinoma and clinicopathologic factors.
World journal of surgical oncology 2013 11 (1): 291. Choi Sun Yi, Park Heonsoo, Kang Myung Koo, Lee Dong Kun, Lee Kang Dae, Lee Hyoung Shin, Kim Sung Won, Lee Eun Nam, Hong Jong Ch |
|
BRAF V600E mutation and its association with clinicopathological features of papillary thyroid cancer: a meta-analysis.
The Journal of clinical endocrinology and metabolism 2012 Dec 97 (12): 4559-70. Li Carol, Lee Kathleen C, Schneider Eric B, Zeiger Martha |
|
BRAF(V600E) status adds incremental value to current risk classification systems in predicting papillary thyroid carcinoma recurrence.
Surgery 2012 Dec 152 (6): 6. Prescott JD, Sadow PM, Hodin RA, Le LP, Gaz RD, Randolph GW, Stephen AE, Parangi S, Daniels GH, Lubitz CC |
|
KRAS and BRAF mutation status in circulating colorectal tumor cells and their correlation with primary and metastatic tumor tissue.
International journal of cancer. Journal international du cancer 2012 Dec . Mostert B, Jiang Y, Sieuwerts AM, Wang H, Vries JB, Biermann K, Kraan J, Lalmahomed Z, van Galen A, de Weerd V, van der Spoel P, Ramírez-Moreno R, Verhoef C, Ijzermans JN, Wang Y, Gratama JW, Foekens JA, Sleijfer S, Martens JW |
|
The role of CCND1 alterations during the progression of cutaneous malignant melanoma.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2012 Dec 33 (6): 2189-99. Vízkeleti Laura, Ecsedi Szilvia, Rákosy Zsuzsa, Orosz Adrienn, Lázár Viktória, Emri Gabriella, Koroknai Viktória, Kiss Tímea, Ádány Róza, Balázs Marg |
|
BRAF (V600E) Mutation Analysis in Papillary Thyroid Carcinomas by Peptide Nucleic Acid Clamp Real-time PCR.
Annals of surgical oncology 2012 Nov . Jeong D, Jeong Y, Park JH, Han SW, Kim SY, Kim YJ, Kim SJ, Hwangbo Y, Park S, Cho HD, Oh MH, Yang SH, Kim CJ |
|
BRAF(V600E) mutation in Turkish patients with papillary thyroid cancer: strong correlation with indicators of tumor aggressiveness.
Endocrine 2012 Oct 42 (2): 404-10. Kurtulmus Neslihan, Duren Mete, Ince Umit, Cengiz Yakicier M, Peker Onder, Ayd?n Ozlem, Altiok Ender, Giray Serdar, Azizlerli Hal |
|
BRAF V600E Mutation Independently Predicts Central Compartment Lymph Node Metastasis in Patients with Papillary Thyroid Cancer.
Annals of surgical oncology 2012 Sep . Howell GM, Nikiforova MN, Carty SE, Armstrong MJ, Hodak SP, Stang MT, McCoy KL, Nikiforov YE, Yip L |
|
The relationship of the BRAF(V600E) mutation and the established prognostic factors in papillary thyroid carcinomas.
Endocrine pathology 2012 Sep 23 (3): 135-40. Kurt Bülent, Yalç?n Serap, Alagöz Engin, Karsl?o?lu Y?ld?r?m, Yigit Nuri, Günal Arma?an, Deveci M Sal |
|
Prediction of Occult Central Lymph Node Metastasis in Papillary Thyroid Carcinoma by Preoperative BRAF Analysis Using Fine-Needle Aspiration Biopsy: A Prospective Study.
The Journal of clinical endocrinology and metabolism 2012 Aug . Joo JY, Park JY, Yoon YH, Choi B, Kim JM, Jo YS, Shong M, Koo BS |
|
BRAF V600E mutation in papillary thyroid carcinoma: significant association with node metastases and extra thyroidal invasion.
Endocrine pathology 2012 Jun 23 (2): 83-93. Chakraborty Avik, Narkar Archana, Mukhopadhyaya Rita, Kane Shubhada, D'Cruz Anil, Rajan M G |
|
Papillary thyroid carcinomas with cervical lymph node metastases can be stratified into clinically relevant prognostic categories using oncogenic BRAF, the number of nodal metastases, and extra-nodal extension.
Thyroid : official journal of the American Thyroid Association 2012 Jun 22 (6): 575-84. Ricarte-Filho Julio, Ganly Ian, Rivera Michael, Katabi Nora, Fu Weimin, Shaha Ashok, Tuttle R Michael, Fagin James A, Ghossein Rona |
|
A combined molecular-pathologic score improves risk stratification of thyroid papillary microcarcinoma.
Cancer 2012 Apr 118 (8): 2069-77. Niemeier Leo A, Kuffner Akatsu Haruko, Song Chi, Carty Sally E, Hodak Steven P, Yip Linwah, Ferris Robert L, Tseng George C, Seethala Raja R, Lebeau Shane O, Stang Michael T, Coyne Christopher, Johnson Jonas T, Stewart Andrew F, Nikiforov Yuri |
|
BRAFV600E mutation does not serve as a prognostic factor in Korean patients with papillary thyroid carcinoma.
Auris, nasus, larynx 2012 Apr 39 (2): 198-203. Ahn Dongbin, Park June Sik, Sohn Jin Ho, Kim Jae Hyug, Park Sun-Kyun, Seo An Na, Park Ji You |
|
Follicular variant of papillary thyroid cancer: encapsulated, nonencapsulated, and diffuse: distinct biologic and clinical entities.
Archives of otolaryngology--head & neck surgery 2012 Mar 138 (3): 227-33. Gupta Sachin, Ajise Oluyomi, Dultz Linda, Wang Beverly, Nonaka Daisuke, Ogilvie Jennifer, Heller Keith S, Patel Kepal |
|
Phase II study of irinotecan and cetuximab given every 2 weeks as second-line therapy for advanced colorectal cancer.
Clinical colorectal cancer 2012 Mar 11 (1): 53-9. Carneiro Benedito A, Ramanathan Ramesh K, Fakih Marwan G, Krishnamurthi Smitha S, Lembersky Barry C, Stoller Ronald G, Lancaster Stewart L, Pinkerton Richard A, Crandall Theodore L, Schmotzer Amy R, Potter Douglas M, Bahary Nath |
|
Poorer prognosis and higher prevalence of BRAF (V600E) mutation in synchronous bilateral papillary thyroid carcinoma.
Annals of surgical oncology 2012 Jan 19 (1): 31-6. Wang Weibin, Zhao Wenhe, Wang Haiyong, Teng Xiaodong, Wang Haohao, Chen Xiangheng, Li Zhongqi, Yu Xiongfei, Fahey Thomas J, Teng Liso |
|
BRAFV600E status and clinical characteristics in solitary and multiple papillary thyroid carcinoma: experience of 512 cases at a clinical center in China.
World journal of surgical oncology 2012 10 104. Zheng Xiangqian, Xia Tingting, Lin Lin, Gao Songyuan, Lee Yigong, Yu Yang, Wei Songfeng, Gao Mi |
|
Copy number amplification of the PIK3CA gene is associated with poor prognosis in non-lymph node metastatic head and neck squamous cell carcinoma.
BMC cancer 2012 12 (1): 416. Suda Toshihito, Hama Takanori, Kondo Shu, Yuza Yuki, Yoshikawa Mamoru, Urashima Mitsuyoshi, Kato Takakuni, Moriyama Hiros |
|
BRAF(V600E) Mutation is Associated with Tumor Aggressiveness in Papillary Thyroid Cancer.
World journal of surgery 2011 Dec . Kim SJ, Lee KE, Myong JP, Park JH, Jeon YK, Min HS, Park SY, Jung KC, Koo DH, Youn YK |
|
Intratumoural lymph vessel density is related to presence of lymph node metastases and separates encapsulated from infiltrative papillary thyroid carcinoma.
Virchows Archiv : an international journal of pathology 2011 Dec 459 (6): 595-605. Eloy C, Santos J, Soares P, Sobrinho-Simões |
|
Notch1 receptor as a marker of lymph node metastases in papillary thyroid cancer.
Cancer science 2011 Nov . Park HS, Jung CK, Lee SH, Chae BJ, Lim DJ, Park WC, Song BJ, Kim JS, Jung SS, Bae JS |
|
The status of EGFR-associated genes could predict the outcome and tumor response of chemo-refractory metastatic colorectal patients using cetuximab and chemotherapy.
Journal of surgical oncology 2011 Nov 104 (6): 661-6. Lin Jen-Kou, Lin An-Jen, Lin Chun-Chi, Lan Yuan-Tzu, Yang Shung-Haur, Li Anna Fen-Yau, Chang Shih-Chi |
|
Higher rate of BRAF mutation in papillary thyroid cancer over time: a single-institution study.
Cancer 2011 Oct 117 (19): 4390-5. Mathur Aarti, Moses Willeford, Rahbari Reza, Khanafshar Elham, Duh Quan-Yang, Clark Orlo, Kebebew Electr |
|
The preeminence of growth pattern and invasiveness and the limited influence of BRAF and RAS mutations in the occurrence of papillary thyroid carcinoma lymph node metastases.
Virchows Archiv : an international journal of pathology 2011 Sep 459 (3): 265-76. Eloy Catarina, Santos Joana, Soares Paula, Sobrinho-Simões Manu |
|
BRAF(V600E) mutation is associated with an increased risk of nodal recurrence requiring reoperative surgery in patients with papillary thyroid cancer.
Surgery 2010 Dec 148 (6): 1139-45; discussion 1145-6. O'Neill Christine J, Bullock Martyn, Chou Angela, Sidhu Stan B, Delbridge Leigh W, Robinson Bruce G, Gill Anthony J, Learoyd Diana L, Clifton-Bligh Roderick, Sywak Mark |
|
Multiple genetic alterations in papillary thyroid cancer are associated with younger age at presentation.
The Journal of surgical research 2010 May 160 (2): 179-83. Moses Willieford, Weng Julie, Khanafshar Elham, Duh Quan-Yang, Clark Orlo H, Kebebew Electr |
|
Detectable BRAF mutation in serum DNA samples from patients with papillary thyroid carcinomas.
Head & neck 2010 Feb 32 (2): 229-34. Chuang Tony C Y, Chuang Alice Y C, Poeta Luana, Koch Wayne M, Califano Joseph A, Tufano Ralph |
|
EGFR/KRAS/BRAF mutations in primary lung adenocarcinomas and corresponding locoregional lymph node metastases.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009 Jul 15 (14): 14. Schmid K, Oehl N, Wrba F, Pirker R, Pirker C, Filipits M |
|
[An investigation of BRAF mutation in papillary thyroid carcinoma and its clinical value].
Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics 2009 Jun 26 (3): 310-3. Gong Ri-xiang, Zhou Yang, Luo Shu-hua, Zhang Lin, Zhou B |
|
Analysis of differential BRAF(V600E) mutational status in high aggressive papillary thyroid microcarcinoma.
Annals of surgical oncology 2009 Feb 16 (2): 240-5. Lee Xiaolong, Gao Ming, Ji Yifeng, Yu Yang, Feng Ying, Li Yigong, Zhang Yan, Cheng Wenyuan, Zhao Wenchu |
|
Clinical and pathological features and the BRAF(V600E) mutation in patients with papillary thyroid carcinoma with and without concurrent Hashimoto thyroiditis.
Thyroid : official journal of the American Thyroid Association 2009 Feb 19 (2): 137-41. Kim Suk Kyeong, Song Kee-Ho, Lim So Duk, Lim Young Chang, Yoo Young Bum, Kim Ji Soo, Hwang Tae So |
|
Clinicopathologic significance of BRAF V600E mutation in papillary carcinomas of the thyroid: a meta-analysis.
Cancer 2007 Jul 110 (1): 38-46. Lee Ju-Han, Lee Eung-Seok, Kim Young-S |
|
No correlation between BRAFV600E mutation and clinicopathological features of papillary thyroid carcinomas in Taiwan.
Clinical endocrinology 2005 Oct 63 (4): 461-6. Liu Rue-Tsuan, Chen Yi-Ju, Chou Fong-Fu, Li Chun-Liang, Wu Wei-Li, Tsai Po-Chin, Huang Chao-Cheng, Cheng Jiin-Tsu |
|
[BRAFV599E mutation and RET/PTC rearrangements in papillary thyroid carcinoma].
Zhonghua bing li xue za zhi Chinese journal of pathology 2005 May 34 (5): 270-4. Zhu Xiao-li, Zhou Xiao-yan, Zhu Xiong-ze |
- Page last reviewed:Mar 1, 2018
- Page last updated:Jun 20, 2019
- Content source: